4(5)-phenylimidazole has been researched along with methyl-thiohydantoin-tryptophan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dounay, AB; Tuttle, JB; Verhoest, PR | 1 |
| Dong, QQ; Sun, SY; Tang, W; Wang, XX; Wu, XX; Xing, YQ | 1 |
| Liu, HM; Tang, K; Wang, B; Yu, B | 1 |
3 review(s) available for 4(5)-phenylimidazole and methyl-thiohydantoin-tryptophan
| Article | Year |
|---|---|
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.
Topics: Animals; Antineoplastic Agents; Central Nervous System Diseases; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Kynurenine 3-Monooxygenase; Signal Transduction; Transaminases | 2015 |
Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Topics: | 2019 |
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors and PROTAC-based degraders for cancer therapy.
Topics: Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Molecular Structure; Neoplasms; Proteolysis; Small Molecule Libraries | 2022 |